- Home
- HCA vs GSK Comparison
HCA vs GSK Comparison
Compare HCA & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCA | GSK |
|---|---|---|
| Founded | 1968 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.3B | 102.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HCA | GSK |
|---|---|---|
| Price | $469.88 | $48.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $472.12 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 3.6M |
| Earning Date | 01-27-2026 | 02-04-2026 |
| Dividend Yield | 0.61% | ★ 3.48% |
| EPS Growth | 15.74 | ★ 118.57 |
| EPS | ★ 25.82 | 1.79 |
| Revenue | ★ $74,372,000,000.00 | $43,237,357,842.00 |
| Revenue This Year | $8.35 | $6.70 |
| Revenue Next Year | $4.44 | $5.10 |
| P/E Ratio | $18.17 | ★ $13.21 |
| Revenue Growth | ★ 6.82 | 2.73 |
| 52 Week Low | $295.00 | $32.38 |
| 52 Week High | $520.00 | $51.46 |
Technical Indicators
Market Signals| Indicator | HCA | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 43.61 |
| Support Level | $466.01 | $49.32 |
| Resistance Level | $487.09 | $50.87 |
| Average True Range (ATR) | 10.49 | 0.74 |
| MACD | 0.24 | -0.18 |
| Stochastic Oscillator | 28.33 | 5.79 |
Price Performance
Historical ComparisonAbout HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.